Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

122

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

DLBS1033

1 DLBS1033 tablet 490 mg thrice daily for 2 months

DRUG

placebo tablet of DLBS1033

1 placebo tablet of DLBS1033 thrice daily for 2 months

Trial Locations (1)

Department of Internal Medicine, Faculty of Medicine, University of Andalas/ dr. M. Djamil Padang Hospital, Padang